首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
NivolumabMyasthenia gravis: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2017年
/ 1672卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-017-37019-3
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:202 / 202
相关论文
共 50 条
[41]
PenicillamineMyasthenia gravis: case report
Reactions Weekly,
2012,
1424
(1)
: 41
-
41
[42]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2021,
1846
(1)
: 260
-
260
[43]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2019,
1776
(1)
: 364
-
364
[44]
TislelizumabMyasthenia gravis: case report
Reactions Weekly,
2024,
2025
(1)
: 437
-
437
[45]
AtezolizumabMyasthenia gravis: case report
Reactions Weekly,
2022,
1912
(1)
: 99
-
99
[46]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2021,
1873
(1)
: 207
-
207
[47]
LorlatinibMyasthenia gravis: case report
Reactions Weekly,
2018,
1715
(1)
: 164
-
164
[48]
AlemtuzumabMyasthenia gravis: case report
Reactions Weekly,
2019,
1751
(1)
: 19
-
19
[49]
Myasthenia gravis - With report of a case
Rosenheck, C
论文数:
0
引用数:
0
h-index:
0
机构:
Columbia Univ, Coll Phys & Surg, New York, NY USA
Columbia Univ, Coll Phys & Surg, New York, NY USA
Rosenheck, C
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1919,
72
: 1211
-
1212
[50]
CemiplimabMyasthenia gravis: case report
Reactions Weekly,
2025,
2052
(1)
: 119
-
119
←
1
2
3
4
5
→